Crystal polymorph of magnesium glycinate dihydrate and process for its preparation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9394318
APP PUB NO 20140186408A1
SERIAL NO

14091070

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Embodiments of the invention provide solid forms of magnesium glycinate dihydrate and compositions thereof, which are useful for treating hyperphosphatemia and which exhibit desirable characteristics for the same. The invention further provides processes for the production of solid forms of magnesium glycinate dihydrate.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CURRAX PHARMACEUTICALS LLC10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lewis, Robert L Madison, US 22 226

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 19, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00